Filing Details

Accession Number:
0000899243-19-019500
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-11 21:00:24
Reporting Period:
2019-07-09
Accepted Time:
2019-07-11 21:00:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754125 B. Douglas Snyder Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-07-09 4,968 $14.42 82,920 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on May 14, 2019.
  2. Represented by American Depositary Shares of the Issuer ("ADSs"). Each ADS represents twelve ordinary shares of the Issuer.
  3. The price reported in Column 4 is a price per ordinary share converted from price per ADS.
  4. Includes 56,376 and 26,544 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively.